Terms: = Germ cell tumor AND BRD4, O60885, 23476, ENSG00000141867, HUNKI, CAP, MCAP AND Prognosis
31 results:
1. Repeatedly next-generation sequencing during treatment follow-up of patients with small cell lung cancer.
JiaXin Y; XiaoFeng C; PengFei C; Songchen Z; Ziling L
Medicine (Baltimore); 2023 Jun; 102(26):e34143. PubMed ID: 37390276
[TBL] [Abstract] [Full Text] [Related]
2. Bromodomain and Extraterminal Domain (BET) Protein Inhibition Hinders Glioblastoma Progression by Inducing Autophagy-Dependent Differentiation.
Colardo M; Gargano D; Russo M; Petraroia M; Pensabene D; D'Alessandro G; Santoro A; Limatola C; Segatto M; Di Bartolomeo S
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108181
[TBL] [Abstract] [Full Text] [Related]
3. Identification of therapeutic sensitivities in a spheroid drug combination screen of Neurofibromatosis Type I associated High Grade Gliomas.
Dougherty J; Harvey K; Liou A; Labella K; Moran D; Brosius S; De Raedt T
PLoS One; 2023; 18(2):e0277305. PubMed ID: 36730269
[TBL] [Abstract] [Full Text] [Related]
4. The brd4 Inhibitor dBET57 Exerts Anticancer Effects by Targeting Superenhancer-Related Genes in Neuroblastoma.
Jia SQ; Zhuo R; Zhang ZM; Yang Y; Tao YF; Wang JW; Li XL; Xie Y; Li G; Wu D; Chen YL; Yu JJ; Feng CX; Li ZH; Zhou RF; Yang RD; Yang PC; Zhou B; Wan XM; Wu YM; Jiao WY; Zhou NN; Fang F; Pan J
J Immunol Res; 2022; 2022():7945884. PubMed ID: 36438198
[TBL] [Abstract] [Full Text] [Related]
5. Dissecting super-enhancer driven transcriptional dependencies reveals novel therapeutic strategies and targets for group 3 subtype medulloblastoma.
Li M; Han Y; Wang C; Kang W; Jiang W; Zhang L; Tang Y
J Exp Clin Cancer Res; 2022 Oct; 41(1):311. PubMed ID: 36273157
[TBL] [Abstract] [Full Text] [Related]
6. An inhibitor of brd4, GNE987, inhibits the growth of glioblastoma cells by targeting C-Myc and S100A16.
Ma L; Li G; Yang T; Zhang L; Wang X; Xu X; Ni H
Cancer Chemother Pharmacol; 2022 Dec; 90(6):431-444. PubMed ID: 36224471
[TBL] [Abstract] [Full Text] [Related]
7. Identification of m7G-associated lncRNA prognostic signature for predicting the immune status in cutaneous melanoma.
Rong J; Wang H; Yao Y; Wu Z; Chen L; Jin C; Shi Z; Wu C; Hu X
Aging (Albany NY); 2022 Jun; 14(12):5233-5249. PubMed ID: 35771136
[TBL] [Abstract] [Full Text] [Related]
8. The optimal duration of capecitabine plus temozolomide in patients with well-differentiated pancreatic NETs with or without maintenance therapy.
Gao H; Dong J; Zhang W; Xu H; Ye L; Li H; Wang W; Liu L; Yu X
J Neuroendocrinol; 2022 Jun; 34(6):e13112. PubMed ID: 35380016
[TBL] [Abstract] [Full Text] [Related]
9. brd4 inhibitor MZ1 exerts anti-cancer effects by targeting MYCN and MAPK signaling in neuroblastoma.
Zhang X; Guo X; Zhuo R; Tao Y; Liang W; Yang R; Chen Y; Cao H; Jia S; Yu J; Liao X; Li X; Fang F; Li G; Wu D; Xu Y; Li Z; Pan J; Wang J
Biochem Biophys Res Commun; 2022 May; 604():63-69. PubMed ID: 35299072
[TBL] [Abstract] [Full Text] [Related]
10. Biosafety and differentially expressed genes analysis of melanoma cells treated with cold atmospheric plasma.
Zhao L; Yan C; Kong S; Jia T; Chu Z; Yang L; Wu J; Geng S; Guo K
J Biophotonics; 2022 Jun; 15(6):e202100403. PubMed ID: 35261164
[TBL] [Abstract] [Full Text] [Related]
11. NUT Carcinoma: A Clinical, Morphological and Immunohistochemical Mimicker-The Role of RNA Sequencing in the Diagnostic Procedure.
Gasljevic G; Matter MS; Blatnik O; Unk M; Dirnhofer S
Int J Surg Pathol; 2022 May; 30(3):273-277. PubMed ID: 34738485
[No Abstract] [Full Text] [Related]
12. Targeting non-canonical activation of GLI1 by the SOX2-brd4 transcriptional complex improves the efficacy of HEDGEHOG pathway inhibition in melanoma.
Pietrobono S; Gaudio E; Gagliardi S; Zitani M; Carrassa L; Migliorini F; Petricci E; Manetti F; Makukhin N; Bond AG; Paradise BD; Ciulli A; Fernandez-Zapico ME; Bertoni F; Stecca B
Oncogene; 2021 Jun; 40(22):3799-3814. PubMed ID: 33958721
[TBL] [Abstract] [Full Text] [Related]
13. MORPHOLOGICAL DIAGNOSIS OF PANCREATIC NEUROENDOCRINE tumorS (REVIEW AND CASE REPORT).
Opanasenko D; Krychevska O; Kuryk O; Zakhartseva L; Rudnytska O
Georgian Med News; 2020 Nov; (308):101-109. PubMed ID: 33395650
[TBL] [Abstract] [Full Text] [Related]
14. Evaluation of hepatic drug-metabolism for glioblastoma using liver-brain chip.
Li Z; Li D; Guo Y; Wang Y; Su W
Biotechnol Lett; 2021 Feb; 43(2):383-392. PubMed ID: 33145669
[TBL] [Abstract] [Full Text] [Related]
15. BET inhibitor suppresses melanoma progression
Deng G; Zeng F; Su J; Zhao S; Hu R; Zhu W; Hu S; Chen X; Yin M
Theranostics; 2020; 10(25):11428-11443. PubMed ID: 33052224
[No Abstract] [Full Text] [Related]
16. Combination of metformin and cold atmospheric plasma induces glioma cell death to associate with c-Fos.
Yang F; Zhou Y; Yu H; Yang J; Zhu C; Ahmad N; Meng X; Zhao R; Zhuang J; Sun M
Neoplasma; 2021 Jan; 68(1):126-134. PubMed ID: 32880467
[TBL] [Abstract] [Full Text] [Related]
17. Epigenetic Targeting of
Huang M; Zeki J; Sumarsono N; Coles GL; Taylor JS; Danzer E; Bruzoni M; Hazard FK; Lacayo NJ; Sakamoto KM; Dunn JCY; Spunt SL; Chiu B
Cancer Res; 2020 Mar; 80(5):1024-1035. PubMed ID: 31900258
[TBL] [Abstract] [Full Text] [Related]
18. Targeting cyclin-dependent kinase 9 sensitizes medulloblastoma cells to chemotherapy.
Song H; Bhakat R; Kling MJ; Coulter DW; Chaturvedi NK; Ray S; Joshi SS
Biochem Biophys Res Commun; 2019 Dec; 520(2):250-256. PubMed ID: 31594641
[TBL] [Abstract] [Full Text] [Related]
19. JMJD6 is a tumorigenic factor and therapeutic target in neuroblastoma.
Wong M; Sun Y; Xi Z; Milazzo G; Poulos RC; Bartenhagen C; Bell JL; Mayoh C; Ho N; Tee AE; Chen X; Li Y; Ciaccio R; Liu PY; Jiang CC; Lan Q; Jayatilleke N; Cheung BB; Haber M; Norris MD; Zhang XD; Marshall GM; Wang JY; Hüttelmaier S; Fischer M; Wong JWH; Xu H; Perini G; Dong Q; George RE; Liu T
Nat Commun; 2019 Jul; 10(1):3319. PubMed ID: 31346162
[TBL] [Abstract] [Full Text] [Related]
20. Cold Atmospheric Plasma as an Adjunct to Immunotherapy for Glioblastoma Multiforme.
Almeida ND; Klein AL; Hogan EA; Terhaar SJ; Kedda J; Uppal P; Sack K; Keidar M; Sherman JH
World Neurosurg; 2019 Oct; 130():369-376. PubMed ID: 31284051
[TBL] [Abstract] [Full Text] [Related]
[Next]